Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;54(12):2037-2053.
doi: 10.1111/imj.16557. Epub 2024 Nov 26.

A review and recommendations on the management of psoriatic arthritis in Australia 2024

Peter Nash  1   2   3 , Daniel Sumpton  4 , Michelle Tellus  5 , Marie Feletar  6 , Paul Bird  7 , Stephen Hall  8   9
Affiliations
Review

A review and recommendations on the management of psoriatic arthritis in Australia 2024

Peter Nash et al. Intern Med J. 2024 Dec.

Abstract

Psoriatic arthritis (PsA) is a progressive, systemic inflammatory disease. It can lead to serious joint damage and disability, increased cardiovascular risk and reduced quality of life. Six experts met to develop the recommendations for the management of PsA in Australia. The final recommendations are approved by all panel members. Management and treatment recommendations have been made under six subheadings: Recommendations for non-steroidal anti-inflammatory drugs and glucocorticoids; Disease-modifying treatment; Screening and monitoring; Family planning; Symptom treatment and extra-articular manifestations; Comorbidities and lifestyle considerations. Our recommendations for the management of PsA in Australia draw heavily on the established global guidelines. These recommendations aim to assist clinicians to make informed, patient-centric choices when delivering treatment to people with PsA.

Keywords: Australia; pharmacotherapy; psoriatic arthritis; psoriatic arthritis drug therapy.

PubMed Disclaimer

References

    1. Karmacharya P, Chakradhar R, Ogdie A. The epidemiology of psoriatic arthritis: a literature review. Best Pract Res Clin Rheumatol 2021; 35: 101692.
    1. Boehncke WH, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol 2013; 14: 377–388.
    1. Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond) 2017; 17: 65–70.
    1. Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol 2022; 18: 465–479.
    1. Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020; 79: 700–712.

Publication types

MeSH terms

Substances

Grants and funding